Boston, MA 02108
The LSX World Congress USA combines plenaries, workshops, panels, a two track global investment showcase, fireside chars, therapeutic roundtables, an IPO bootcamp and one-to-one meetings to give life science companies everything they need to enable more effective partnering, investment, planning and strategic growth.
Interactive workshops EU-US Public Finance - EU CxOs and expert advisers discuss the how, what, where and when of a successful US IPO and follow-on fundraise. Pharma Business Development Leaders - Global and regional BD heads from Pharma and large-cap Biotech companies discuss and shape the future of their sector under Chatham House Rule Mergers & Acquisitions – CEOs and CFOs navigate the how, what, where and when of a successful M&A.
Thought-Provoking Panels Understand the latest trends, forecasts and insights from leading investment funds, life science company executives, pharma BD&L heads and industry KOLs.
Insightful Interviews Listen to war stories, advice and key success factors from CEOs who have gone public, secured big licencing deals or raised significant fund privately in our fireside chats.
Focused Therapeutic Leaders Forums Focussed on immuno-oncology, neuroscience and cell & gene therapy with keynote talks, pertinent case studies and open and frank peer-debate under chatham House Rule.
IPO Bootcamp Immerse yourself in the full-day US Life Science IPO Bootcamp in which a team of some of the world’s foremost experts, advisers, bankers and consultants help CEOs and CFOs navigate the how, what, where and when of a successful US IPO.
1-2-1 Meetings Meet and partner through the exclusive LSX 1-2-1 partnering system to find investors, scout investment opportunities and connect with potential partners.
Why the LSX World Congress USA? CxO level - quality without the fluff
High-quality speakers from investors, biotechs and pharma
Connecting the EU and US by bringing select high-quality European corporates and investors to Boston
Unique therapeutically focussed leaders forums
Forward-looking agenda to educate investors and corporates on the most exciting new technology and therapeutic areas in healthcare today
8 reasons to attend:
1.UNDERSTAND... the latest trends, forecasts and insights from leading investment funds, life science company executives, pharma BD&L heads and industry KOLs.
2.NETWORK... with 400+ life science CXOs, investors and pharma convening to address key executive issues facing their businesses and the wider healthcare sector.
3.LISTEN TO... war stories, advice and key success factors from CEOs who have gone public, secured big licencing deals or raised significant fund privately in our fireside chats.
4.PRESENT... your company to an audience of qualified investors and pharma BD&L in the Inv€$table showcase sessions.
5.PARTICIPATE... in our unique invitation-only Chatham House Rule sub-sector leaders’forums focussed on some of the most exciting areas in life sciences.
6.JOIN... intimate workshops run by the industry’s foremost experts to help prepare your company for key milestones and explore innovative models for company growth.
7.MEET AND PARTNER... through the exclusive LSX 1-2-1 partnering system to find investors, scout investment opportunities and connect with potential partners.
8.CONNECT WITH PURPOSE... to our community - the life science executives of LSX.
The event is organised by LSX, the network for life science executive leaders, formally known as Biotech and Money.
Full details can be seen at: https://www.biotechandmoney.com/lsx-usa-congress